Who Buys Heparin from India — 854 Importers Behind a $352.8M Market
India's heparin import market is served by 854 active buyers who collectively imported $352.8M across 4,586 shipments. FRESENIUS KABI USA, LLC (UNITED STATES) leads with a 12.8% market share, followed by BOSTON ONCOLOGY ARABIA and NUEVOS ETICOS NEOETHICALS, S.A.. The top 5 buyers together control 45.5% of total import value, reflecting a moderately competitive buyer landscape.
Top Heparin Importers — Ranked by Import Value
FRESENIUS KABI USA, LLC (UNITED STATES) is the leading heparin importer from India, holding a 12.8% share of the $352.8M market across 4,586 shipments from 854 buyers. The top 5 buyers — FRESENIUS KABI USA, LLC (UNITED STATES), BOSTON ONCOLOGY ARABIA (SAUDI ARABIA), NUEVOS ETICOS NEOETHICALS, S.A. (GUATEMALA), EVERSANA (UNITED STATES), HOSPIRA INC (UNITED STATES) — collectively control 45.5% of total import value.
Top Heparin Buyers & Importers
Ranked by import value · 854 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | FRESENIUS KABI USA, LLCUNITED STATES HEPARIN 30000U/30ML SSOL 1X25 MDVHEPARIN 5000IU/ML SSOL 25X1ML SDV | $45.1M | 5 | 12.8% |
| 2 | BOSTON ONCOLOGY ARABIASAUDI ARABIA LOW MOLECULAR WEIGHT HEPARIN ENOXAPARIN | $42.1M | 5 | 11.9% |
| 3 | NUEVOS ETICOS NEOETHICALS, S.A.GUATEMALA HEPARIN INJECTIONHEPARIN SODIUM INJECTION USP 5000IU/ML -5MLHEPARIN SODIUM INJECTION USP 5000IU/ML -5MLVIAL | $28.8M | 5 | 8.2% |
| 4 | EVERSANAUNITED STATES HEPARIN 30000U/30ML SSOL 1X25 MDVHEPARIN 5000IU/ML SSOL 25X1ML SDV | $28.2M | 5 | 8.0% |
| 5 | HOSPIRA INCUNITED STATES HEPARIN 30000U/30ML SSOL 1X25 MDVHEPARIN 5000IU/ML SSOL 25X1ML SDV | $16.3M | 5 | 4.6% |
| 6 | FRESENIUS KABI USA LLCUNITED STATES HEPARIN 30000U/30ML SSOL 1X25 MDVHEPARIN 5000IU/ML SSOL 25X1ML SDV | $11.8M | 5 | 3.3% |
| 7 | MYLAN INSTITUTIONAL INC 2898UNITED STATES HEPARIN 30000U/30ML SSOL 1X25 MDVHEPARIN 5000IU/ML SSOL 25X1ML SDV | $9.5M | 5 | 2.7% |
| 8 | XXSPIXX INXUNITED STATES HEPARIN 30000U/30ML SSOL 1X25 MDVHEPARIN 5000IU/ML SSOL 25X1ML SDV | $9.3M | 5 | 2.6% |
| 9 | E U PHARMACEUTICALS CO.,LTDTHAILAND LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINHEPARIN 30000U/30ML SSOL 1X25 MDVHEPARIN INJECTION BP 25000 IU/5ML,5ML VI | $7.8M | 5 | 2.2% |
| 10 | EVERSANA EVERSANAUNITED STATES HEPARIN 30000U/30ML SSOL 1X25 MDVHEPARIN 5000IU/ML SSOL 25X1ML SDV | $7.4M | 5 | 2.1% |
| 11 | EVERSANA LIFE SCIENCE SERVICES LLCUNITED STATES HEPARIN 30000U/30ML SSOL 1X25 MDVHEPARIN 5000IU/ML SSOL 25X1ML SDV | $7.1M | 5 | 2.0% |
| 12 | NORDIC PHARMACEUTICAL COMPANY SACPERU HEPARIN SODIUM INJECTION BP 25000 IU/5MLHEPARIN SODIUM INJECTIONBP 25000 IU/5MLHEPARIN INJECTION BP 25000IU/5ML5ML VIAL | $7.0M | 5 | 2.0% |
| 13 | M/S. OOO JODAS EXPOIM..RUSSIA HEPARIN SODIUM SOLUTION FOR INTRAVENOUSHEPARIN-RUS 25000 IUHEPARIN - RUS 25000 IU | $5.8M | 5 | 1.6% |
| 14 | STATE PHARMACEUTICALS CORPORATIONSRI LANKA LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINHEPARIN INJECTION BP5000IU/ML-5ML VIALSHLOW MOLECULAR WEIGHTHEPARIN ENOXAPARINSO | $5.1M | 5 | 1.5% |
| 15 | FRESENIUS KABI USA LLC,UNITED STATES HEPARIN 30000U/30ML SSOL 1X25 MDVHEPARIN 5000IU/ML SSOL 25X1ML SDV | $4.8M | 5 | 1.4% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Heparin — and from which countries?
Flow of Heparin exports from India: each country's share and the named importers behind the numbers
Heparin — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $148.5M through 913 shipments. This represents a market share of 42.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• FRESENIUS KABI USA, LLC - $45.1M (30.4% of country's total business)
• EVERSANA - $28.2M (19.0% of country's total business)
• HOSPIRA INC - $16.3M (11.0% of country's total business)
• FRESENIUS KABI USA LLC - $11.8M (7.9% of country's total business)
• MYLAN INSTITUTIONAL INC 2898 - $9.5M (6.4% of country's total business)
• Rest of United States's importers - $37.6M (25.3% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $162.6K, indicating premium pricing strategy compared to the market average of $76.9K.
United States is a key market for Heparin imports, representing 42.1% of total trade value.
2Saudi Arabia
Saudi Arabia emerges as the second largest importing country, achieving a total trade value of $43.5M through 223 shipments. This represents a market share of 12.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Saudi Arabia has a diverse importer base, with their top importers including:
• BOSTON ONCOLOGY ARABIA - $42.1M (96.8% of country's total business)
Key Insight: Saudi Arabia demonstrates strong market positioning with an average shipment value of $195.2K, indicating premium pricing strategy compared to the market average of $76.9K.
Saudi Arabia is a key market for Heparin imports, representing 12.3% of total trade value.
3Guatemala
Guatemala emerges as the third largest importing country, achieving a total trade value of $30.6M through 22 shipments. This represents a market share of 8.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Guatemala has a diverse importer base, with their top importers including:
• NUEVOS ETICOS NEOETHICALS, S.A. - $28.8M (94.2% of country's total business)
Key Insight: Guatemala demonstrates strong market positioning with an average shipment value of $1.4M, indicating premium pricing strategy compared to the market average of $76.9K.
Guatemala is a key market for Heparin imports, representing 8.7% of total trade value.
4Thailand
Thailand emerges as the fourth largest importing country, achieving a total trade value of $27.3M through 28 shipments. This represents a market share of 7.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Thailand has a diverse importer base, with their top importers including:
• E U PHARMACEUTICALS CO.,LTD - $7.8M (28.7% of country's total business)
Key Insight: Thailand demonstrates strong market positioning with an average shipment value of $976.7K, indicating premium pricing strategy compared to the market average of $76.9K.
Thailand is a key market for Heparin imports, representing 7.8% of total trade value.
5Philippines
Philippines emerges as the fifth largest importing country, achieving a total trade value of $14.4M through 0 shipments. This represents a market share of 4.1% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Philippines demonstrates strong market positioning with an average shipment value of $14.4M, indicating premium pricing strategy compared to the market average of $76.9K.
Philippines is a key market for Heparin imports, representing 4.1% of total trade value.
Buyer Segment Analysis
TransData Nexus Heparin buyer market intelligence
1Buyer Segment Analysis
The buyer landscape for Indian heparin imports encompasses several key segments:
1. Distributors: Entities like EVERSANA (United States, $28.18M) and E U Pharmaceuticals Co., Ltd (Thailand, $7.84M) function as intermediaries, purchasing heparin in bulk to supply hospitals, clinics, and pharmacies. Their buying behavior is characterized by large, regular orders to maintain a steady supply chain.
2. Hospital Groups: Organizations such as Fresenius Kabi USA, LLC (United States, $45.10M) and Hospira Inc (United States, $16.34M) procure heparin directly for use within their healthcare facilities. Their purchasing patterns are driven by patient demand and treatment protocols, often resulting in consistent, sizable orders.
3. Government Procurement: While specific entities like UNICEF or national health ministries are not listed among the top buyers, government procurement plays a significant role in heparin distribution. These bodies typically engage in tender-based purchasing, emphasizing cost-effectiveness and supply reliability to meet public health needs.
4. Re-exporters: Companies such as Boston Oncology Arabia (Saudi Arabia, $42.14M) may act as re-exporters, importing heparin for distribution to neighboring regions. Their order sizes can vary, influenced by regional demand and trade agreements.
5. Contract Manufacturers: Entities like Mylan Institutional Inc (United States, $9.48M) may procure heparin as a raw material for producing finished pharmaceutical products. Their purchasing behavior is aligned with production schedules and market demand for heparin-based medications.
Each segment's procurement strategies are tailored to their operational needs, with factors such as regulatory compliance, market demand, and supply chain logistics influencing their order patterns.
Country-Specific Import Regulations
TransData Nexus Heparin buyer market intelligence
1Country-Specific Import Regulations
United States
1. Drug Regulatory Authority: Food and Drug Administration (FDA).
2. Import Registration Process for Heparin: Importers must submit analytical data with each shipment, including SAX-HPLC chromatograms and 1D-1H-NMR spectra, to ensure compliance with USP specifications and FDA standards.
3. Estimated Timeline for Registration: The FDA reviews import documentation on a case-by-case basis; timelines can vary depending on compliance and completeness of submissions.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this code are generally subject to a 0% import duty, but importers should verify current rates with U.S. Customs and Border Protection.
Saudi Arabia
1. Drug Regulatory Authority: Saudi Food and Drug Authority (SFDA).
2. Import Registration Process for Heparin: Importers must register pharmaceutical products with the SFDA, providing comprehensive documentation on product quality, safety, and efficacy.
3. Estimated Timeline for Registration: The registration process typically takes 6 to 12 months, depending on the completeness of the application and SFDA's review workload.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products are generally exempt from import duties in Saudi Arabia, but importers should confirm current rates with Saudi Customs.
Guatemala
1. Drug Regulatory Authority: Ministry of Public Health and Social Assistance (MSPAS).
2. Import Registration Process for Heparin: Importers are required to submit product registration applications to MSPAS, including detailed information on product composition, manufacturing processes, and quality control measures.
3. Estimated Timeline for Registration: The registration process can take approximately 6 to 9 months, subject to the thoroughness of the application and MSPAS's review schedule.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products may be subject to import duties; importers should consult the latest tariff schedules from Guatemala's Superintendency of Tax Administration (SAT).
Thailand
1. Drug Regulatory Authority: Thai Food and Drug Administration (Thai FDA).
2. Import Registration Process for Heparin: Importers must obtain product registration approval from the Thai FDA, providing comprehensive dossiers that include clinical data, manufacturing details, and labeling information.
3. Estimated Timeline for Registration: The registration process typically takes 12 to 18 months, depending on the complexity of the product and the completeness of the application.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products are generally exempt from import duties in Thailand, but importers should verify current rates with the Thai Customs Department.
Philippines
1. Drug Regulatory Authority: Food and Drug Administration Philippines (FDA Philippines).
2. Import Registration Process for Heparin: Importers must secure a Certificate of Product Registration (CPR) from FDA Philippines, submitting detailed documentation on product quality, safety, and efficacy.
3. Estimated Timeline for Registration: The registration process can take 6 to 12 months, depending on the completeness of the submission and the FDA's review process.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products are generally subject to a 0% import duty, but importers should confirm current rates with the Bureau of Customs.
Demand Drivers & Market Opportunity
TransData Nexus Heparin buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for heparin in importing countries is primarily driven by the prevalence of cardiovascular diseases, which require anticoagulant therapy. According to the World Health Organization (WHO), cardiovascular diseases remain the leading cause of death globally, underscoring the consistent need for heparin. Additionally, the inclusion of heparin in the WHO Model List of Essential Medicines highlights its critical role in healthcare systems worldwide. (who.int)
Government healthcare programs and the expansion of universal health coverage further bolster heparin demand. Many countries implement tender-based procurement systems to ensure the availability of essential medicines like heparin in public health facilities. For instance, centralized procurement arrangements have been shown to improve the distribution of essential medicines to primary care institutions, enhancing access and affordability. With 854 buyers across 137 countries, the global market for heparin presents substantial opportunities for suppliers to meet the ongoing and growing needs of diverse healthcare systems.
Common Questions — Heparin Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest heparin buyer importing from India?
Based on import volume and value, FRESENIUS KABI USA, LLC (UNITED STATES) leads with $45.1M in imports and a 12.8% market share — the highest of any single heparin importer. BOSTON ONCOLOGY ARABIA (SAUDI ARABIA) and NUEVOS ETICOS NEOETHICALS, S.A. (GUATEMALA) are the next largest buyers.
QHow many companies buy heparin from India?
There are 854 active heparin buyers importing from India, with a combined market of $352.8M across 4,586 shipments to 137 countries. The top 5 buyers hold 45.5% of total import value, while the remaining 849 buyers handle the other 54.5%.
QWhich countries import the most heparin from India?
The top importing countries for heparin from India are United States (42.1%), Saudi Arabia (12.3%), Guatemala (8.7%), Thailand (7.8%), Philippines (4.1%). These markets represent the largest demand centres for Indian pharmaceutical exports of heparin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for heparin from India?
The average import transaction value for heparin from India is $76.9K, with an average unit price of $58.66 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Heparin buyer market intelligence
1Buyer Segment Analysis
The buyer landscape for Indian heparin imports encompasses several key segments:
1. Distributors: Entities like EVERSANA (United States, $28.18M) and E U Pharmaceuticals Co., Ltd (Thailand, $7.84M) function as intermediaries, purchasing heparin in bulk to supply hospitals, clinics, and pharmacies. Their buying behavior is characterized by large, regular orders to maintain a steady supply chain.
2. Hospital Groups: Organizations such as Fresenius Kabi USA, LLC (United States, $45.10M) and Hospira Inc (United States, $16.34M) procure heparin directly for use within their healthcare facilities. Their purchasing patterns are driven by patient demand and treatment protocols, often resulting in consistent, sizable orders.
3. Government Procurement: While specific entities like UNICEF or national health ministries are not listed among the top buyers, government procurement plays a significant role in heparin distribution. These bodies typically engage in tender-based purchasing, emphasizing cost-effectiveness and supply reliability to meet public health needs.
4. Re-exporters: Companies such as Boston Oncology Arabia (Saudi Arabia, $42.14M) may act as re-exporters, importing heparin for distribution to neighboring regions. Their order sizes can vary, influenced by regional demand and trade agreements.
5. Contract Manufacturers: Entities like Mylan Institutional Inc (United States, $9.48M) may procure heparin as a raw material for producing finished pharmaceutical products. Their purchasing behavior is aligned with production schedules and market demand for heparin-based medications.
Each segment's procurement strategies are tailored to their operational needs, with factors such as regulatory compliance, market demand, and supply chain logistics influencing their order patterns.
Country-Specific Import Regulations
TransData Nexus Heparin buyer market intelligence
1Country-Specific Import Regulations
United States
1. Drug Regulatory Authority: Food and Drug Administration (FDA).
2. Import Registration Process for Heparin: Importers must submit analytical data with each shipment, including SAX-HPLC chromatograms and 1D-1H-NMR spectra, to ensure compliance with USP specifications and FDA standards.
3. Estimated Timeline for Registration: The FDA reviews import documentation on a case-by-case basis; timelines can vary depending on compliance and completeness of submissions.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this code are generally subject to a 0% import duty, but importers should verify current rates with U.S. Customs and Border Protection.
Saudi Arabia
1. Drug Regulatory Authority: Saudi Food and Drug Authority (SFDA).
2. Import Registration Process for Heparin: Importers must register pharmaceutical products with the SFDA, providing comprehensive documentation on product quality, safety, and efficacy.
3. Estimated Timeline for Registration: The registration process typically takes 6 to 12 months, depending on the completeness of the application and SFDA's review workload.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products are generally exempt from import duties in Saudi Arabia, but importers should confirm current rates with Saudi Customs.
Guatemala
1. Drug Regulatory Authority: Ministry of Public Health and Social Assistance (MSPAS).
2. Import Registration Process for Heparin: Importers are required to submit product registration applications to MSPAS, including detailed information on product composition, manufacturing processes, and quality control measures.
3. Estimated Timeline for Registration: The registration process can take approximately 6 to 9 months, subject to the thoroughness of the application and MSPAS's review schedule.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products may be subject to import duties; importers should consult the latest tariff schedules from Guatemala's Superintendency of Tax Administration (SAT).
Thailand
1. Drug Regulatory Authority: Thai Food and Drug Administration (Thai FDA).
2. Import Registration Process for Heparin: Importers must obtain product registration approval from the Thai FDA, providing comprehensive dossiers that include clinical data, manufacturing details, and labeling information.
3. Estimated Timeline for Registration: The registration process typically takes 12 to 18 months, depending on the complexity of the product and the completeness of the application.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products are generally exempt from import duties in Thailand, but importers should verify current rates with the Thai Customs Department.
Philippines
1. Drug Regulatory Authority: Food and Drug Administration Philippines (FDA Philippines).
2. Import Registration Process for Heparin: Importers must secure a Certificate of Product Registration (CPR) from FDA Philippines, submitting detailed documentation on product quality, safety, and efficacy.
3. Estimated Timeline for Registration: The registration process can take 6 to 12 months, depending on the completeness of the submission and the FDA's review process.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products are generally subject to a 0% import duty, but importers should confirm current rates with the Bureau of Customs.
Demand Drivers & Market Opportunity
TransData Nexus Heparin buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for heparin in importing countries is primarily driven by the prevalence of cardiovascular diseases, which require anticoagulant therapy. According to the World Health Organization (WHO), cardiovascular diseases remain the leading cause of death globally, underscoring the consistent need for heparin. Additionally, the inclusion of heparin in the WHO Model List of Essential Medicines highlights its critical role in healthcare systems worldwide. (who.int)
Government healthcare programs and the expansion of universal health coverage further bolster heparin demand. Many countries implement tender-based procurement systems to ensure the availability of essential medicines like heparin in public health facilities. For instance, centralized procurement arrangements have been shown to improve the distribution of essential medicines to primary care institutions, enhancing access and affordability. With 854 buyers across 137 countries, the global market for heparin presents substantial opportunities for suppliers to meet the ongoing and growing needs of diverse healthcare systems.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 854 global importers of Heparin identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 4,586 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 137 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4,586 Verified Shipments
854 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists